After setback, Rhythm gets good news on Imcivree from FDA Rhythm Pharma has secured the first approval in the US for a drug to treat hypothalamic obesity.

#RhythmPharma has secured the first approval in the US for a drug to treat #hypothalamicobesity, a #rarecondition in which damage to or a malfunction of the hypothalamus leads to excessive #weightgain.

Hypothalamic Obesity (HyOb): Symptoms, Causes, and More Hypothalamic obesity is a rare type of obesity caused by damage to the brain's hunger-regulating function. Learn more.

Hypothalamic Obesity: What You Need to Know

www.healthline.com/health/obesi...

#hyop #hypothalamicobesity #health #wellness @healthline.bsky.social Healthline

Setmelanotide Safe, Efficacious in Treating Acquired Hypothalamic Obesity Setmelanotide was associated with significant weight reduction among patients aged 4 years and older with acquired hypothalamic obesity.

From #ENDO2025: #Setmelanotide was associated with significant #WeightReduction among adult and pediatric patients with acquired #HypothalamicObesity.

@endocrinesociety.bsky.social @ucsdhealth.bsky.social @themaximacenter.bsky.social @sickkidsto.bsky.social @childrensphila.bsky.social

Research Opportunity - Seattle Children's is studying tirzepatide in young adults (18–26) with #PraderWilliSyndrome and #HypothalamicObesity.

For information, contact EndocrineResearch@seattlechildrens.org | 206-987-2540

Join us for a Rare Disease Week virtual discussion with Dr. Jennifer Miller, leading expert in hypothalamic obesity! Learn how patient participation drives research & advances treatment for rare conditions. Register now: zurl.co/pOqtD #RareDiseaseWeek #HypothalamicObesity #RareDisease